Daily estimation of the severity of organ dysfunctions in critically ill children by using the PELOD-2 scor
Critical
Care 2015, 19:324
Leteurtre
S et al
Introduction: Daily or serial evaluation of multiple organ dysfunction
syndrome (MODS) scores may provide useful information. We aimed to validate the
daily (d) PELOD-2 score using the set of seven days proposed with the previous
version of the score.
Methods: In all consecutive patients admitted to nine
pediatric intensive care units (PICUs) we prospectively measured the dPELOD-2
score at day 1, 2, 5, 8, 12, 16, and 18. PICU mortality was used as the outcome
dependent variable. The discriminant power of the dPELOD-2 scores was estimated
using the area under the ROC curve and the calibration using the
Hosmer-Lemeshow chi-square test. We used a logistic regression to investigate
the relationship between the dPELOD-2 scores and outcome, and between the
change in PELOD-2 score from day1 and outcome. Results: We included 3669 patients (median age 15.5 months, mortality rate 6.1
%, median length of PICU stay 3 days). Median dPELOD-2 scores were
significantly higher in nonsurvivors than in survivors (p < 0.0001). The
dPELOD-2 score was available at least at day 2 in 2057 patients: among the 796
patients without MODS on day1, 186 (23.3 %) acquired the syndrome during their
PICU stay (mortality 4.9 % vs. 0.3 % among the 610 who did not; p < 0.0001).
Among the1261 patients with MODS on day1, the syndrome worsened in 157 (12.4 %)
and remained unchanged or improved in 1104 (87.6 %) (mortality 22.9 % vs. 6.6
%; p < 0.0001). The AUC of the dPELOD-2 scores ranged from 0.75 (95 % CI:
0.67-0.83) to 0.89 (95 % CI: 0.86-0.91). The calibration was good with a
chi-square test between 13.5 (p = 0.06) and 0.9 (p = 0.99). The PELOD-2 score
on day1 was a significant prognostic factor; the serial evaluation of the
change in the dPELOD-2 score from day1, adjusted for baseline value,
demonstrated a significant odds ratio of death for each of the 7 days. Conclusion: This study suggests that the progression of the severity of organ
dysfunctions can be evaluated by measuring the dPELOD-2 score during a set of 7
days in PICU, providing useful information on outcome in critically ill
children. Its external validation would be useful
No comments:
Post a Comment
Note: only a member of this blog may post a comment.